Massachusetts General Hospital
This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer
The research study procedures include: screening for eligibility and study questionnaires that would be performed in conjunction with either the genetic counselor visit or use of the electronic decision aid. The study questionnaires include: * Knowledge Survey * Shared Decision Making Process Survey * Decisional Conflict Scale The research study will last up to 2 weeks. It is expected that about 350 people will take part in this research study. The National Cancer Institute (NCI) is supporting this research study by providing funding for the research
Inclusion Criteria: * 18 years or older * Being seen in clinic at Massachusetts General Hospital or Boston Medical Center * Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma. Exclusion Criteria : * Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study * Previous germline genetic testing * History of hereditary pancreatitis * Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults
Decision aid followed by an appointment with an oncologist. Will complete surveys/questionnaires
Receive pretest counseling with a genetic counselor. Will complete surveys/questionnaires
Arctuva estimate
Verify or correct the compensation shown for this listing.